Abstract
We aimed to investigate the clinical factors affecting the therapeutic effectiveness of the sodium-glucose cotransporter-2 inhibitor empagliflozin in patients with type 2 diabetes mellitus (T2DM). We reviewed the medical records of 374 T2DM patients aged between 20 and 75 years who were prescribed empagliflozin 10 mg or 25 mg as add-on therapy for more than 90 consecutive days. Changes in hemoglobin A1c (HbA1c) from baseline levels and the reduction in body weights of the study participants were assessed. We found that younger patients (≤ 50 years), patients with the highest levels of HbA1c (>9%) at baseline, patients with an estimated glomerular filtration rate (eGFR) of >90 mL/min/1.73 m2, and patients with a shorter duration of T2DM (< 10 years) were more likely to exhibit a better glycemic response. Multivariate linear regression analysis revealed that a shorter duration of T2DM, higher baseline levels of HbA1c, and higher eGFR were positively associated with HbA1c reduction. Higher BMI and lower HbA1c levels were predictors of a more significant reduction in body weight among patients taking empagliflozin. The glucose-lowering effect of empagliflozin was more evident in T2DM patients with higher baseline HbA1c levels, bett...Continue Reading
References
May 29, 2010·Nature Reviews. Drug Discovery·Edward C Chao, Robert R Henry
Jun 4, 2010·Diabetes, Obesity & Metabolism·L ZhangM Pfister
Oct 12, 2011·Diabetes, Obesity & Metabolism·R GremplerP Eickelmann
Aug 3, 2013·Diabetes, Obesity & Metabolism·C S KovacsUNKNOWN EMPA-REG PIO™ trial investigators
Aug 22, 2013·Diabetes Care·Hans-Ulrich HäringUNKNOWN EMPA-REG METSU Trial Investigators
Sep 13, 2013·Annals of Internal Medicine·Despoina VasilakouApostolos Tsapas
Sep 26, 2013·Diabetes·Muhammad A Abdul-GhaniLuke Norton
Sep 27, 2013·Kidney International·Donald E KohanJames F List
Mar 14, 2014·The Lancet. Diabetes & Endocrinology·Michael RodenUNKNOWN EMPA-REG MONO trial investigators
Apr 12, 2014·Diabetes Care·Hans-Ulrich HäringUNKNOWN EMPA-REG MET Trial Investigators
Nov 27, 2014·Diabetes Therapy : Research, Treatment and Education of Diabetes and Related Disorders·Sanjay Kalra
Jan 15, 2015·Diabetes Care·Ralph A DeFronzoUli C Broedl
Mar 19, 2015·TheScientificWorldJournal·L ZanoliP Castellino
Apr 16, 2016·Journal of Clinical Medicine Research·Kotaro IemitsuIkuro Matsuba
Apr 27, 2016·Lancet·UNKNOWN NCD Risk Factor Collaboration (NCD-RisC)
Jan 17, 2017·Diabetes & Metabolism·J-Y LeeE S Kang
Jul 7, 2017·Medicine·Jian LiYinghong Shao
Nov 1, 2017·Diabetes & Metabolism Journal·Seung Hyun KoUNKNOWN Committee of Clinical Practice Guideline of Korean Diabetes Association
Dec 1, 2017·Advances in Therapy·Shusuke YagiMasataka Sata
Dec 10, 2017·Diabetes Care·UNKNOWN American Diabetes Association
Sep 27, 2018·Obesity Reviews : an Official Journal of the International Association for the Study of Obesity·P C LeeS-Y Goh
Citations
Feb 5, 2021·Diabetes Care·Nishi Chaturvedi, Sophie Eastwood
Mar 24, 2021·Family Practice·Hanifah DavisThomas Delate
Apr 7, 2021·Clinical Science·Kana N MiyataJohn S D Chan